The incidence of internal malignancies in autoimmune bullous diseases

Tokai Journal of Experimental and Clinical Medicine

Volumn 32, Issue 1, 2007, Pages 42-47

  Iwashita, Kenichi ^a   Matsuyama, Takashi ^a   Akasaka, Emiko ^a   Mizutani, Kimihiko ^a   Yamamoto, Kozo ^a   Kondoh, Akio ^a   Nozawa, Masaki ^a   Yagi, Yoko ^a   Ikoma, Norihiro ^a   Mabuchi, Tomotaka ^a   Shinagawa, Harumi ^a   Tamiya, Shiho ^a   Nuruki, Hiroko ^a   Ohta, Yukinori ^a   Umezawa, Yoshinori ^a   Ozawa, Akira ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoimmune bullous diseases; BP; Bullous pemphigoid; Internal malignancy; Pemphigus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE BULLOUS DISEASE; BLADDER CANCER; BREAST CANCER; BULLOUS PEMPHIGOID; COLORECTAL CANCER; DISEASE SEVERITY; ERYTHEMATOUS PEMPHIGUS; FEMALE; HUMAN; INCIDENCE; JAPANESE; KIDNEY PELVIS CARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VEGETANS; PEMPHIGUS VULGARIS; PROSTATE CANCER; RECTUM CANCER; RETROSPECTIVE STUDY; SCREENING; STOMACH CANCER; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PEMPHIGOID, BULLOUS; PEMPHIGUS; YOUNG ADULT;

EID: 57149112778     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Goldsmith LA. Pathogenesis, pharmacology and progress: a meeting report of pemphigus 2005 - progress and future directions, held June 16-17, 2005 in Bethesda, Maryland (USA). J Invest Dermatol 125: vii-viii, 2005.
2. Wojnarowska F, Venning VA, Burge SM. Immunobullous Diseases. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. Seventh edition. Massachusetts: Blackwell Publishing, 2004: Chapter 41.
3. Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai S, Imamura S, et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci 9: 136-141, 1995.
4. Ishii N, Hashimoto T. The statistical study of the pemphigus patients for ten years recently in Kurume university dermatology. Annual Report From Orphan Intractable Skin Disease Subgroup, the Ministry of Health, Labor and Welfare. 2006. (in print)
5. The outpatient visit rate. In: Hasegawa K, Eto H, Sekino H, Miyazaki A, Aoki R, Maeda Y, et al., eds. Annual Statistical Report of National Health Conditions [in Japanese]. 2005 ed. Tokyo, Japan: Health and Welfare Statistics Association, 2005; 52 (annual extra-edition of Journal of Health and Welfare Statistics): 416-417.
6. The Japanese population. In: Hasegawa K, Eto H, Sekino H, Miyazaki A, Aoki R, Maeda Y, et al., eds. Annual Statistical Report of National Health Conditions [in Japanese]. 2005 ed. Tokyo, Japan: Health and Welfare Statistics Association, 2005; 52 (annual extra-edition of Journal of Health and Welfare Statistics): 356.
7. Ikeda S. Pemphigus Severity Assessment Criteria (Draft Revision). In: First and Second National Surveys on Pemphigus Severity Assessment Criteria (Draft Revision) [in Japanese]. Annual Report From Orphan Intractable Skin Disease Subgroup, Ministry of Health and Welfare Designated Skin/Connective Tissue Disease Research Group, 1997: 79.
8. Venning VA, Wojnarowska F. The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 123: 439-445, 1990.
9. Sonobe A, Iwashita K, Umezawa Y, Ozawa A, Komai A, et al. Paraneoplastic pemphigus successfully treated with topical corticosteroid. Rinsho Derma 46: 1815-1818, 2004.